Literature DB >> 21720873

An update on molecular genetics of Alkaptonuria (AKU).

Andrea Zatkova1.   

Abstract

Alkaptonuria (AKU) is an autosomal recessive disorder caused by a deficiency of homogentisate 1,2 dioxygenase (HGD) and characterized by homogentisic aciduria, ochronosis, and ochronotic arthritis. The defect is caused by mutations in the HGD gene, which maps to the human chromosome 3q21-q23. AKU shows a very low prevalence (1:100,000-250,000) in most ethnic groups, but there are countries such as Slovakia and the Dominican Republic in which the incidence of this disorder rises to as much as 1:19,000. In this work, we summarize the genetic aspects of AKU in general and the distribution of all known disease-causing mutations reported so far. We focus on special features of AKU in Slovakia, which is one of the countries with an increased incidence of this rare metabolic disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21720873     DOI: 10.1007/s10545-011-9363-z

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  46 in total

1.  Sequence analysis of the homogentisate 1,2 dioxygenase gene in a family affected by alkaptonuria.

Authors:  K Walter; A Gaa; H E Schaefer
Journal:  J Med Genet       Date:  1999-08       Impact factor: 6.318

2.  Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.

Authors:  Laura Tinti; Adriano Spreafico; Daniela Braconi; Lia Millucci; Giulia Bernardini; Federico Chellini; Giovanni Cavallo; Enrico Selvi; Mauro Galeazzi; Roberto Marcolongo; James A Gallagher; Annalisa Santucci
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

3.  Identification of 11 Novel Homogentisate 1,2 Dioxygenase Variants in Alkaptonuria Patients and Establishment of a Novel LOVD-Based HGD Mutation Database.

Authors:  Andrea Zatkova; Tatiana Sedlackova; Jan Radvansky; Helena Polakova; Martina Nemethova; Robert Aquaron; Ismail Dursun; Jeannette L Usher; Ludevit Kadasi
Journal:  JIMD Rep       Date:  2011-10-20

4.  Ochronotic rheumatism in Algeria: clinical, radiological, biological and molecular studies--a case study of 14 patients in 11 families.

Authors:  Aicha Ladjouze-Rezig; Santiago Rodriguez de Cordoba; Robert Aquaron
Journal:  Joint Bone Spine       Date:  2005-07-07       Impact factor: 4.929

5.  The molecular basis of alkaptonuria.

Authors:  J M Fernández-Cañón; B Granadino; D Beltrán-Valero de Bernabé; M Renedo; E Fernández-Ruiz; M A Peñalva; S Rodríguez de Córdoba
Journal:  Nat Genet       Date:  1996-09       Impact factor: 38.330

6.  A novel therapeutic trial of homogentisic aciduria in a murine model of alkaptonuria.

Authors:  Y Suzuki; K Oda; Y Yoshikawa; Y Maeda; T Suzuki
Journal:  J Hum Genet       Date:  1999       Impact factor: 3.172

7.  Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers.

Authors:  L Ranganath; A M Taylor; A Shenkin; W D Fraser; J Jarvis; J A Gallagher; N Sireau
Journal:  J Inherit Metab Dis       Date:  2011-02-11       Impact factor: 4.982

8.  Familiar ochronotic arthropathy-caused by a gene mutation traced three hundred years.

Authors:  Kálmán Tóth; Zsuzsanna Kiss-Láaszló; Endre Lénárt; Katalin Juhász; Katalin Takács; Tamas Bender; Janos Szabó
Journal:  Joint Bone Spine       Date:  2010-05-13       Impact factor: 4.929

Review 9.  Alkaptonuria in Slovakia: thirty-two years of research on phenotype and genotype.

Authors:  Stefan Srsen; Clemens R Müller; Andreas Fregin; Klara Srsnova
Journal:  Mol Genet Metab       Date:  2002-04       Impact factor: 4.797

10.  SNAP: predict effect of non-synonymous polymorphisms on function.

Authors:  Yana Bromberg; Burkhard Rost
Journal:  Nucleic Acids Res       Date:  2007-05-25       Impact factor: 16.971

View more
  33 in total

1.  Alkaptonuria Severity Score Index Revisited: Analysing the AKUSSI and Its Subcomponent Features.

Authors:  Bryony Langford; Megan Besford; Aimée Hall; Lucy Eddowes; Oliver Timmis; James A Gallagher; Lakshminarayan Ranganath
Journal:  JIMD Rep       Date:  2018-04-14

2.  Identification of 11 Novel Homogentisate 1,2 Dioxygenase Variants in Alkaptonuria Patients and Establishment of a Novel LOVD-Based HGD Mutation Database.

Authors:  Andrea Zatkova; Tatiana Sedlackova; Jan Radvansky; Helena Polakova; Martina Nemethova; Robert Aquaron; Ismail Dursun; Jeannette L Usher; Ludevit Kadasi
Journal:  JIMD Rep       Date:  2011-10-20

3.  A case of 'blue skin' and 'dark urine'.

Authors:  Sandeep Arora; Neha Sodhi; Arun Kumar Harith; Umesh Kapoor
Journal:  Med J Armed Forces India       Date:  2017-08-18

4.  Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment.

Authors:  A S Davison; B Norman; A M Milan; A T Hughes; M Khedr; J Rovensky; J A Gallagher; L R Ranganath
Journal:  JIMD Rep       Date:  2017-11-17

5.  Investigating the Robustness and Diagnostic Potential of Extracellular Matrix Remodelling Biomarkers in Alkaptonuria.

Authors:  F Genovese; A S Siebuhr; K Musa; J A Gallagher; A M Milan; M A Karsdal; J Rovensky; A C Bay-Jensen; L R Ranganath
Journal:  JIMD Rep       Date:  2015-03-19

Review 6.  A two-electron-shell game: intermediates of the extradiol-cleaving catechol dioxygenases.

Authors:  Andrew J Fielding; John D Lipscomb; Lawrence Que
Journal:  J Biol Inorg Chem       Date:  2014-03-11       Impact factor: 3.358

7.  Identification of Homogentisate Dioxygenase as a Target for Vitamin E Biofortification in Oilseeds.

Authors:  Minviluz G Stacey; Rebecca E Cahoon; Hanh T Nguyen; Yaya Cui; Shirley Sato; Cuong T Nguyen; Nongnat Phoka; Kerry M Clark; Yan Liang; Joe Forrester; Josef Batek; Phat Tien Do; David A Sleper; Thomas E Clemente; Edgar B Cahoon; Gary Stacey
Journal:  Plant Physiol       Date:  2016-09-22       Impact factor: 8.340

8.  Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone.

Authors:  A S Davison; B P Norman; E A Smith; J Devine; J Usher; A T Hughes; M Khedr; A M Milan; J A Gallagher; L R Ranganath
Journal:  JIMD Rep       Date:  2018-05-13

9.  Analysis of Melanin-like Pigment Synthesized from Homogentisic Acid, with or without Tyrosine, and Its Implications in Alkaptonuria.

Authors:  Adam M Taylor; Koen P Vercruysse
Journal:  JIMD Rep       Date:  2016-12-10

Review 10.  Acute fatal metabolic complications in alkaptonuria.

Authors:  A S Davison; A M Milan; J A Gallagher; L R Ranganath
Journal:  J Inherit Metab Dis       Date:  2015-11-23       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.